Latest News about Johnson & Johnson
Recent news which mentions Johnson & Johnson
What to watch today: Stock futures fall as the 10-year Treasury yield tops a 3-year high
April 18, 2022
From CNBC.com News
5 things to know before the stock market opens Monday
April 18, 2022
From CNBC.com News
From Best Stocks
From CNBC.com News
From CNBC.com News
Tickers
HART
From ETF Trends
From CNBC.com News
Tickers
RH
From CNBC.com News
5 things to know before the stock market opens Wednesday
March 30, 2022
From CNBC.com News
Johnson & Johnson MedTech Earns a Spot on Fast Company's 2022 Most Innovative Companies List
March 29, 2022
Tickers
JNJ
From CNBC.com News
Pfizer planning to submit data on 4th Covid shot soon, while working on vaccine for all variants
March 11, 2022
Tickers
LIFE
From CNBC.com News
This ETF is designed to help fight heart disease while making you money. Here’s how
February 16, 2022
From CNBC.com News
Moderna, Pfizer stocks fall as omicron Covid wave subsides in U.S.
February 14, 2022
From CNBC.com News
From CNBC.com News
Johnson & Johnson plant pauses Covid vaccine production, report says
February 08, 2022
From CNBC.com News
Moderna's Covid vaccine for teens awaits OK as regulators review heart inflammation risk
February 04, 2022
From CNBC.com News
Hollywood agencies are betting big on TikTok talent as they seek to woo Gen Z audiences
January 30, 2022
Tickers
LIFE
From CNBC.com News
Cramer says the stock market is being dragged down by 2021's flurry of IPOs and SPAC deals
January 25, 2022
From CNBC.com News
From CNBC.com News
Stocks making the biggest moves midday: American Express, General Electric, IBM and more
January 25, 2022
From CNBC.com News
Cramer advises investors to stick with 'great American companies' to weather market swings
January 25, 2022
From CNBC.com News
From CNBC.com News
5 things to know before the stock market opens Tuesday
January 25, 2022
From CNBC.com News
Stocks making the biggest moves in the premarket: 3M, Johnson & Johnson, General Electric and more
January 25, 2022
From CNBC.com News
J&J expects more than $3 billion in Covid vaccine sales this year in mixed quarterly report
January 25, 2022
From CNBC.com News
From CNBC.com News
From CNBC.com News
‘Boring’ is the new black – Kevin O'Leary on how he’s investing in a rising inflation environment
January 21, 2022
From CNBC.com News
Johnson & Johnson is spinning off its consumer division, which could come with risks
January 10, 2022
Tickers
LIFE
From CNBC.com News
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.